Sign in Sign up for free

Cotinga Pharmaceuticals Short % of float

What is the Short % of float of Cotinga Pharmaceuticals?

The Short % of float of Cotinga Pharmaceuticals, Inc. is 0.00%

What is the definition of Short % of float?



Short percentage of float is the amount of shares being shorted compared to the float expressed as a percentage.

= short interest / float shares

Short percentage of float, or short interest ratio, is calculated by taking the total amount of shares shorted and dividing it by the total amount of shares available for trade. It is an indirect metric of investor sentiment. When short percentage of float is high, above 40%, it implies company investors hope shares will decline in value. The percentage is used by both fundamental and technical traders to identify trends. The short percentage of float can also be calculated for entire exchanges to determine the sentiment of the market as a whole. If it is high of around five or greater for an exchange, this can be taken as a bearish signal, and vice versa.

Short % of float of companies in the Health Care sector on TSXV compared to Cotinga Pharmaceuticals

What does Cotinga Pharmaceuticals do?

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.

Companies with short % of float similar to Cotinga Pharmaceuticals